---
document_datetime: 2025-12-02 05:36:43
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/ulipristal-acetate-gedeon-richter.html
document_name: ulipristal-acetate-gedeon-richter.html
version: success
processing_time: 0.1431752
conversion_datetime: 2025-12-24 14:58:17.568899
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Ulipristal Acetate Gedeon Richter

[RSS](/en/individual-human-medicine.xml/66576)

##### Withdrawn

This medicine's authorisation has been withdrawn

ulipristal acetate Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Ulipristal Acetate Gedeon Richter](#news-on)
- [More information on Ulipristal Acetate Gedeon Richter](#related-medicines)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 14 June 2021, the European Commission withdrew the marketing authorisation for Ulipristal Acetate Gedeon Richter (ulipristal acetate) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Gedeon Richter Plc., which notified the European Commission of its decision not to market the product in the EU for commercial reasons.

Ulipristal Acetate Gedeon Richter was granted marketing authorisation in the EU on 27 August 2018 for the treatment of uterine fibroids. The marketing authorisation was initially valid for a 5-year period.

Ulipristal Acetate Gedeon Richter was a duplicate application to Esmya, which is marketed in several EU countries.

The European Public Assessment Report (EPAR) for Ulipristal Acetate Gedeon Richter is updated to indicate that the marketing authorisation is no longer valid.

Ulipristal Acetate Gedeon Richter : EPAR - Medicine overview

English (EN) (721.33 KB - PDF)

**First published:** 06/09/2018

**Last updated:** 02/07/2021

[View](/en/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_en.pdf-0)

[Other languages (22)](#file-language-dropdown-137)

български (BG) (805.8 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/bg/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_bg.pdf-0)

español (ES) (708.53 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/es/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_es.pdf-0)

čeština (CS) (781.02 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/cs/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_cs.pdf-0)

dansk (DA) (705.89 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/da/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_da.pdf-0)

Deutsch (DE) (711.46 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/de/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_de.pdf-0)

eesti keel (ET) (694.54 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/et/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_et.pdf-0)

ελληνικά (EL) (805.14 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/el/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_el.pdf-0)

français (FR) (710.29 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/fr/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_fr.pdf-0)

hrvatski (HR) (734.95 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/hr/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_hr.pdf-0)

italiano (IT) (706 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/it/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_it.pdf-0)

latviešu valoda (LV) (156.85 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/lv/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_lv.pdf-0)

lietuvių kalba (LT) (733.64 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/lt/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_lt.pdf-0)

magyar (HU) (779.92 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/hu/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_hu.pdf-0)

Malti (MT) (793.31 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/mt/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_mt.pdf-0)

Nederlands (NL) (707.03 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/nl/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_nl.pdf-0)

polski (PL) (781.89 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/pl/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_pl.pdf-0)

português (PT) (698.7 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/pt/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_pt.pdf-0)

română (RO) (734.45 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/ro/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_ro.pdf-0)

slovenčina (SK) (784.27 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/sk/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_sk.pdf-0)

slovenščina (SL) (779.14 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/sl/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_sl.pdf-0)

Suomi (FI) (705.48 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/fi/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_fi.pdf-0)

svenska (SV) (706.53 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/sv/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_sv.pdf-0)

Ulipristal Acetate Gedeon Richter : EPAR - Medicine overview

English (EN) (721.33 KB - PDF)

**First published:** 06/09/2018

**Last updated:** 02/07/2021

[View](/en/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_en.pdf)

[Other languages (22)](#file-language-dropdown-797)

български (BG) (805.8 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/bg/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_bg.pdf)

español (ES) (708.53 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/es/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_es.pdf)

čeština (CS) (781.02 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/cs/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_cs.pdf)

dansk (DA) (705.89 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/da/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_da.pdf)

Deutsch (DE) (711.46 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/de/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_de.pdf)

eesti keel (ET) (694.54 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/et/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_et.pdf)

ελληνικά (EL) (805.14 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/el/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_el.pdf)

français (FR) (710.29 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/fr/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_fr.pdf)

hrvatski (HR) (734.95 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/hr/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_hr.pdf)

italiano (IT) (706 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/it/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_it.pdf)

latviešu valoda (LV) (156.85 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/lv/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_lv.pdf)

lietuvių kalba (LT) (733.64 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/lt/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_lt.pdf)

magyar (HU) (779.92 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/hu/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_hu.pdf)

Malti (MT) (793.31 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/mt/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_mt.pdf)

Nederlands (NL) (707.03 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/nl/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_nl.pdf)

polski (PL) (781.89 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/pl/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_pl.pdf)

português (PT) (698.7 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/pt/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_pt.pdf)

română (RO) (734.45 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/ro/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_ro.pdf)

slovenčina (SK) (784.27 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/sk/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_sk.pdf)

slovenščina (SL) (779.14 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/sl/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_sl.pdf)

Suomi (FI) (705.48 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/fi/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_fi.pdf)

svenska (SV) (706.53 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/sv/documents/overview/ulipristal-acetate-gedeon-richter-epar-medicine-overview_sv.pdf)

Ulipristal Acetate Gedeon Richter : EPAR - Risk-management-plan summary

English (EN) (814.11 KB - PDF)

**First published:** 03/02/2021

**Last updated:** 02/07/2021

[View](/en/documents/rmp-summary/ulipristal-acetate-gedeon-richter-epar-risk-management-plan-summary_en.pdf)

## Product information

Ulipristal Acetate Gedeon Richter : EPAR - Product Information

English (EN) (1.01 MB - PDF)

**First published:** 06/09/2018

**Last updated:** 02/07/2021

[View](/en/documents/product-information/ulipristal-acetate-gedeon-richter-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-288)

български (BG) (1.87 MB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/bg/documents/product-information/ulipristal-acetate-gedeon-richter-epar-product-information_bg.pdf)

español (ES) (1006.84 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/es/documents/product-information/ulipristal-acetate-gedeon-richter-epar-product-information_es.pdf)

čeština (CS) (980.38 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/cs/documents/product-information/ulipristal-acetate-gedeon-richter-epar-product-information_cs.pdf)

dansk (DA) (985.58 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/da/documents/product-information/ulipristal-acetate-gedeon-richter-epar-product-information_da.pdf)

Deutsch (DE) (1.04 MB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/de/documents/product-information/ulipristal-acetate-gedeon-richter-epar-product-information_de.pdf)

eesti keel (ET) (931.37 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/et/documents/product-information/ulipristal-acetate-gedeon-richter-epar-product-information_et.pdf)

ελληνικά (EL) (1.98 MB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/el/documents/product-information/ulipristal-acetate-gedeon-richter-epar-product-information_el.pdf)

français (FR) (1018.25 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/fr/documents/product-information/ulipristal-acetate-gedeon-richter-epar-product-information_fr.pdf)

hrvatski (HR) (1.07 MB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/hr/documents/product-information/ulipristal-acetate-gedeon-richter-epar-product-information_hr.pdf)

íslenska (IS) (975.68 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/is/documents/product-information/ulipristal-acetate-gedeon-richter-epar-product-information_is.pdf)

italiano (IT) (974.64 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/it/documents/product-information/ulipristal-acetate-gedeon-richter-epar-product-information_it.pdf)

latviešu valoda (LV) (1.8 MB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/lv/documents/product-information/ulipristal-acetate-gedeon-richter-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.8 MB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/lt/documents/product-information/ulipristal-acetate-gedeon-richter-epar-product-information_lt.pdf)

magyar (HU) (1.56 MB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/hu/documents/product-information/ulipristal-acetate-gedeon-richter-epar-product-information_hu.pdf)

Malti (MT) (1.62 MB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/mt/documents/product-information/ulipristal-acetate-gedeon-richter-epar-product-information_mt.pdf)

Nederlands (NL) (967.06 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/nl/documents/product-information/ulipristal-acetate-gedeon-richter-epar-product-information_nl.pdf)

norsk (NO) (973.21 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/no/documents/product-information/ulipristal-acetate-gedeon-richter-epar-product-information_no.pdf)

polski (PL) (1.59 MB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/pl/documents/product-information/ulipristal-acetate-gedeon-richter-epar-product-information_pl.pdf)

português (PT) (987.36 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/pt/documents/product-information/ulipristal-acetate-gedeon-richter-epar-product-information_pt.pdf)

română (RO) (1.09 MB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/ro/documents/product-information/ulipristal-acetate-gedeon-richter-epar-product-information_ro.pdf)

slovenčina (SK) (1.55 MB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/sk/documents/product-information/ulipristal-acetate-gedeon-richter-epar-product-information_sk.pdf)

slovenščina (SL) (1.5 MB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/sl/documents/product-information/ulipristal-acetate-gedeon-richter-epar-product-information_sl.pdf)

Suomi (FI) (1013.08 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/fi/documents/product-information/ulipristal-acetate-gedeon-richter-epar-product-information_fi.pdf)

svenska (SV) (948.19 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/sv/documents/product-information/ulipristal-acetate-gedeon-richter-epar-product-information_sv.pdf)

14/06/2021

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Ulipristal Acetate Gedeon Richter : EPAR - All Authorised presentations

English (EN) (597.46 KB - PDF)

**First published:** 06/09/2018

**Last updated:** 02/07/2021

[View](/en/documents/all-authorised-presentations/ulipristal-acetate-gedeon-richter-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-202)

български (BG) (640.72 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/bg/documents/all-authorised-presentations/ulipristal-acetate-gedeon-richter-epar-all-authorised-presentations_bg.pdf)

español (ES) (597.33 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/es/documents/all-authorised-presentations/ulipristal-acetate-gedeon-richter-epar-all-authorised-presentations_es.pdf)

čeština (CS) (622.2 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/cs/documents/all-authorised-presentations/ulipristal-acetate-gedeon-richter-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (596.79 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/da/documents/all-authorised-presentations/ulipristal-acetate-gedeon-richter-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (597.21 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/de/documents/all-authorised-presentations/ulipristal-acetate-gedeon-richter-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (597 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/et/documents/all-authorised-presentations/ulipristal-acetate-gedeon-richter-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (640.57 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/el/documents/all-authorised-presentations/ulipristal-acetate-gedeon-richter-epar-all-authorised-presentations_el.pdf)

français (FR) (597.63 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/fr/documents/all-authorised-presentations/ulipristal-acetate-gedeon-richter-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (606.66 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/hr/documents/all-authorised-presentations/ulipristal-acetate-gedeon-richter-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (597.28 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/is/documents/all-authorised-presentations/ulipristal-acetate-gedeon-richter-epar-all-authorised-presentations_is.pdf)

italiano (IT) (596.99 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/it/documents/all-authorised-presentations/ulipristal-acetate-gedeon-richter-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (634.12 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/lv/documents/all-authorised-presentations/ulipristal-acetate-gedeon-richter-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (617.71 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/lt/documents/all-authorised-presentations/ulipristal-acetate-gedeon-richter-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (629.46 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/hu/documents/all-authorised-presentations/ulipristal-acetate-gedeon-richter-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (630.46 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/mt/documents/all-authorised-presentations/ulipristal-acetate-gedeon-richter-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (597.66 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/nl/documents/all-authorised-presentations/ulipristal-acetate-gedeon-richter-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (597.55 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/no/documents/all-authorised-presentations/ulipristal-acetate-gedeon-richter-epar-all-authorised-presentations_no.pdf)

polski (PL) (622.63 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/pl/documents/all-authorised-presentations/ulipristal-acetate-gedeon-richter-epar-all-authorised-presentations_pl.pdf)

português (PT) (597.51 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/pt/documents/all-authorised-presentations/ulipristal-acetate-gedeon-richter-epar-all-authorised-presentations_pt.pdf)

română (RO) (616.82 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/ro/documents/all-authorised-presentations/ulipristal-acetate-gedeon-richter-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (622.69 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/sk/documents/all-authorised-presentations/ulipristal-acetate-gedeon-richter-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (621.01 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/sl/documents/all-authorised-presentations/ulipristal-acetate-gedeon-richter-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (597.62 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/fi/documents/all-authorised-presentations/ulipristal-acetate-gedeon-richter-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (590.12 KB - PDF)

**First published:**

06/09/2018

**Last updated:**

02/07/2021

[View](/sv/documents/all-authorised-presentations/ulipristal-acetate-gedeon-richter-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Ulipristal Acetate Gedeon Richter Active substance ulipristal acetate International non-proprietary name (INN) or common name ulipristal acetate Therapeutic area (MeSH) Leiomyoma Anatomical therapeutic chemical (ATC) code G03XB02

### Pharmacotherapeutic group

Sex hormones and modulators of the genital system

### Therapeutic indication

Ulipristal acetate is indicated for one treatment course of pre-operative treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.

Ulipristal acetate is indicated for intermittent treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age who are not eligible for surgery.

## Authorisation details

EMA product number EMEA/H/C/005017 Marketing authorisation holder

Gedeon Richter Plc.

Gyomroi ut 19-21

Opinion adopted 28/06/2018 Marketing authorisation issued 27/08/2018 Revision 1

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Ulipristal Acetate Gedeon Richter : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (728.11 KB - PDF)

**First published:** 03/02/2021

**Last updated:** 02/07/2021

[View](/en/documents/procedural-steps-after/ulipristal-acetate-gedeon-richter-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Ulipristal Acetate Gedeon Richter / Esmya-H-A-31-1496-C-2041-0049: EPAR - CHMP scientific conclusions and PRAC Assessment report - Article 31

Adopted

Reference Number: EMA/524073/2020

English (EN) (1.4 MB - PDF)

**First published:** 03/02/2021

**Last updated:** 02/07/2021

[View](/en/documents/variation-report/ulipristal-acetate-gedeon-richter-esmya-h-31-1496-c-2041-0049-epar-chmp-scientific-conclusions-and-prac-assessment-report-article-31_en.pdf)

Ulipristal Acetate Gedeon Richter : EPAR - Scientific conclusions - Annex IV

English (EN) (742.71 KB - PDF)

**First published:** 03/02/2021

**Last updated:** 02/07/2021

[View](/en/documents/scientific-conclusion/ulipristal-acetate-gedeon-richter-epar-scientific-conclusions-annex-iv_en.pdf)

[Other languages (24)](#file-language-dropdown-876)

български (BG) (1.16 MB - PDF)

**First published:**

03/02/2021

**Last updated:**

02/07/2021

[View](/bg/documents/scientific-conclusion/ulipristal-acetate-gedeon-richter-epar-scientific-conclusions-annex-iv_bg.pdf)

español (ES) (717.52 KB - PDF)

**First published:**

03/02/2021

**Last updated:**

02/07/2021

[View](/es/documents/scientific-conclusion/ulipristal-acetate-gedeon-richter-epar-scientific-conclusions-annex-iv_es.pdf)

čeština (CS) (1.08 MB - PDF)

**First published:**

03/02/2021

**Last updated:**

02/07/2021

[View](/cs/documents/scientific-conclusion/ulipristal-acetate-gedeon-richter-epar-scientific-conclusions-annex-iv_cs.pdf)

dansk (DA) (776.12 KB - PDF)

**First published:**

03/02/2021

**Last updated:**

02/07/2021

[View](/da/documents/scientific-conclusion/ulipristal-acetate-gedeon-richter-epar-scientific-conclusions-annex-iv_da.pdf)

Deutsch (DE) (809.32 KB - PDF)

**First published:**

03/02/2021

**Last updated:**

02/07/2021

[View](/de/documents/scientific-conclusion/ulipristal-acetate-gedeon-richter-epar-scientific-conclusions-annex-iv_de.pdf)

eesti keel (ET) (780.64 KB - PDF)

**First published:**

03/02/2021

**Last updated:**

02/07/2021

[View](/et/documents/scientific-conclusion/ulipristal-acetate-gedeon-richter-epar-scientific-conclusions-annex-iv_et.pdf)

ελληνικά (EL) (1.12 MB - PDF)

**First published:**

03/02/2021

**Last updated:**

02/07/2021

[View](/el/documents/scientific-conclusion/ulipristal-acetate-gedeon-richter-epar-scientific-conclusions-annex-iv_el.pdf)

français (FR) (724.64 KB - PDF)

**First published:**

03/02/2021

**Last updated:**

02/07/2021

[View](/fr/documents/scientific-conclusion/ulipristal-acetate-gedeon-richter-epar-scientific-conclusions-annex-iv_fr.pdf)

hrvatski (HR) (851.47 KB - PDF)

**First published:**

03/02/2021

**Last updated:**

02/07/2021

[View](/hr/documents/scientific-conclusion/ulipristal-acetate-gedeon-richter-epar-scientific-conclusions-annex-iv_hr.pdf)

íslenska (IS) (708.37 KB - PDF)

**First published:**

03/02/2021

**Last updated:**

02/07/2021

[View](/is/documents/scientific-conclusion/ulipristal-acetate-gedeon-richter-epar-scientific-conclusions-annex-iv_is.pdf)

italiano (IT) (1.33 MB - PDF)

**First published:**

03/02/2021

**Last updated:**

02/07/2021

[View](/it/documents/scientific-conclusion/ulipristal-acetate-gedeon-richter-epar-scientific-conclusions-annex-iv_it.pdf)

latviešu valoda (LV) (1.01 MB - PDF)

**First published:**

03/02/2021

**Last updated:**

02/07/2021

[View](/lv/documents/scientific-conclusion/ulipristal-acetate-gedeon-richter-epar-scientific-conclusions-annex-iv_lv.pdf)

lietuvių kalba (LT) (869.2 KB - PDF)

**First published:**

03/02/2021

**Last updated:**

02/07/2021

[View](/lt/documents/scientific-conclusion/ulipristal-acetate-gedeon-richter-epar-scientific-conclusions-annex-iv_lt.pdf)

magyar (HU) (988.65 KB - PDF)

**First published:**

03/02/2021

**Last updated:**

02/07/2021

[View](/hu/documents/scientific-conclusion/ulipristal-acetate-gedeon-richter-epar-scientific-conclusions-annex-iv_hu.pdf)

Malti (MT) (1.05 MB - PDF)

**First published:**

03/02/2021

**Last updated:**

02/07/2021

[View](/mt/documents/scientific-conclusion/ulipristal-acetate-gedeon-richter-epar-scientific-conclusions-annex-iv_mt.pdf)

Nederlands (NL) (710.99 KB - PDF)

**First published:**

03/02/2021

**Last updated:**

02/07/2021

[View](/nl/documents/scientific-conclusion/ulipristal-acetate-gedeon-richter-epar-scientific-conclusions-annex-iv_nl.pdf)

norsk (NO) (699.99 KB - PDF)

**First published:**

03/02/2021

**Last updated:**

02/07/2021

[View](/no/documents/scientific-conclusion/ulipristal-acetate-gedeon-richter-epar-scientific-conclusions-annex-iv_no.pdf)

polski (PL) (1.01 MB - PDF)

**First published:**

03/02/2021

**Last updated:**

02/07/2021

[View](/pl/documents/scientific-conclusion/ulipristal-acetate-gedeon-richter-epar-scientific-conclusions-annex-iv_pl.pdf)

português (PT) (719.58 KB - PDF)

**First published:**

03/02/2021

**Last updated:**

02/07/2021

[View](/pt/documents/scientific-conclusion/ulipristal-acetate-gedeon-richter-epar-scientific-conclusions-annex-iv_pt.pdf)

română (RO) (879.76 KB - PDF)

**First published:**

03/02/2021

**Last updated:**

02/07/2021

[View](/ro/documents/scientific-conclusion/ulipristal-acetate-gedeon-richter-epar-scientific-conclusions-annex-iv_ro.pdf)

slovenčina (SK) (1013.26 KB - PDF)

**First published:**

03/02/2021

**Last updated:**

02/07/2021

[View](/sk/documents/scientific-conclusion/ulipristal-acetate-gedeon-richter-epar-scientific-conclusions-annex-iv_sk.pdf)

slovenščina (SL) (1001.18 KB - PDF)

**First published:**

03/02/2021

**Last updated:**

02/07/2021

[View](/sl/documents/scientific-conclusion/ulipristal-acetate-gedeon-richter-epar-scientific-conclusions-annex-iv_sl.pdf)

Suomi (FI) (704.64 KB - PDF)

**First published:**

03/02/2021

**Last updated:**

02/07/2021

[View](/fi/documents/scientific-conclusion/ulipristal-acetate-gedeon-richter-epar-scientific-conclusions-annex-iv_fi.pdf)

svenska (SV) (709.6 KB - PDF)

**First published:**

03/02/2021

**Last updated:**

02/07/2021

[View](/sv/documents/scientific-conclusion/ulipristal-acetate-gedeon-richter-epar-scientific-conclusions-annex-iv_sv.pdf)

## Initial marketing authorisation documents

Ulipristal Acetate Gedeon Richter : EPAR - Public assessment report

Adopted

Reference Number: EMA/483416/2018

English (EN) (862.63 KB - PDF)

**First published:** 06/09/2018

**Last updated:** 02/07/2021

[View](/en/documents/assessment-report/ulipristal-acetate-gedeon-richter-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Ulipristal Acetate Gedeon Richter

Adopted

Reference Number: EMA/CHMP/417636/2018

English (EN) (69.67 KB - PDF)

**First published:** 29/06/2018

**Last updated:** 29/06/2018

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-ulipristal-acetate-gedeon-richter_en.pdf)

#### News on Ulipristal Acetate Gedeon Richter

[Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 31  August - 3 September 2020](/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-31-august-3-september-2020) 04/09/2020

[PRAC recommends revoking marketing authorisation of ulipristal acetate for uterine fibroids](/en/news/prac-recommends-revoking-marketing-authorisation-ulipristal-acetate-uterine-fibroids) 04/09/2020

[Suspension of ulipristal acetate for uterine fibroids during ongoing EMA review of liver injury risk](/en/news/suspension-ulipristal-acetate-uterine-fibroids-during-ongoing-ema-review-liver-injury-risk) 13/03/2020

[Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9-12 March 2020](/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-9-12-march-2020) 13/03/2020

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 25-28 June 2018](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-25-28-june-2018) 29/06/2018

#### More information on Ulipristal Acetate Gedeon Richter

- [Ulipristal acetate 5mg medicinal products - referral](/en/medicines/human/referrals/ulipristal-acetate-5mg-medicinal-products)
- [Esmya / Ulipristal Acetate Gedeon Richter - direct healthcare professional communication (DHPC)](/en/medicines/dhpc/esmya-ulipristal-acetate-gedeon-richter)

**This page was last updated on** 09/07/2021

## Share this page

[Back to top](#main-content)